Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations
Jennifer S. Gewandter(University of Rochester), Richard E. White(Endo Pharmaceuticals (United States)), Ian Gilron(Apple (Israel)), Stephen Senn(Edinburgh Royal Infirmary), Michael S. Leong(Stanford University), Karin L. Petersen(San Francisco General Hospital), Charles Taylor(RED Consulting (Norway)), Christine Rauschkolb(Johnson & Johnson (United States)), Marc R. Gastonguay(Metrum Research Group (United States)), Richard L. Leff, Rolf‐Detlef Treede(Heidelberg University), Ralf Baron(Kiel University), Cyrus R. Mehta(Harvard University), David Hewitt(Glasgow Royal Infirmary), Paul J. Desjardins(Rutgers, The State University of New Jersey), Jonathan Stewart(GlaxoSmithKline (Netherlands)), Robert D. Kerns(Yale University), Robert H. Dworkin(University of Rochester Medical Center), Ilona Steigerwald(Grünenthal Group (Germany)), Jeffrey Tobias(Jazz Pharmaceuticals (United States)), Eija Kalso(Helsinki Art Museum), Joseph Stauffer, Raymond A. Dionne(National Institute of Dental and Craniofacial Research), Andrew S.C. Rice(Imperial College London), John T. Farrar(Hospital of the University of Pennsylvania), Srinivasa N. Raja(Johns Hopkins University), Mark S. Wallace, Michael P. McDermott(University of Rochester), Smriti Iyengar(National Institute of Neurological Disorders and Stroke), Dennis C. Turk(University of Washington), Penney Cowan(American Chronic Pain Association), Michael C. Rowbotham(University of California, San Francisco), Rozalina Dimitrova(Allergan (United States)), Nathaniel P. Katz(Wellesley College), Bernard Ravina(Voyager Therapeutics (United States)), Cristina Sampaio(Dorothea Haus Ross Foundation)
Cited by 110
Related Papers
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
|Psychological Bulletin|2007|3.3k
A classification of chronic pain for ICD-11
|Pain|2015|2.8k
Neuropathic pain
|Nature Reviews Disease Primers|2017|2k